These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18333314)

  • 1. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug.
    Suleyman H; Cadirci E; Albayrak A; Halici Z
    Curr Med Chem; 2008; 15(3):278-83. PubMed ID: 18333314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor].
    Bennett A; Vila D
    Vutr Boles; 2000; 32(1):33-6. PubMed ID: 11195195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases].
    Arcimowicz M; Samoliński B; Gotlib T; Nyckowska J
    Otolaryngol Pol; 2002; 56(4):501-7. PubMed ID: 12378813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities.
    Bennett A; Villa G
    Expert Opin Pharmacother; 2000 Jan; 1(2):277-86. PubMed ID: 11249549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
    Fung HB; Kirschenbaum HL
    Clin Ther; 1999 Jul; 21(7):1131-57. PubMed ID: 10463513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
    Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA
    Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
    Bjarnason I; Thjodleifsson B
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A
    Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
    Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
    Caiazzo E; Ialenti A; Cicala C
    Eur J Pharmacol; 2019 Apr; 848():105-111. PubMed ID: 30689999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitors of COX-2--are they safe for the stomach?
    Giercksky KE; Haglund U; Rask-Madsen J
    Scand J Gastroenterol; 2000 Nov; 35(11):1121-4. PubMed ID: 11145280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimesulide: some pharmaceutical and pharmacological aspects--an update.
    Singla AK; Chawla M; Singh A
    J Pharm Pharmacol; 2000 May; 52(5):467-86. PubMed ID: 10864134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.